Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wrightia tinctoria oil is a botanical extract derived from the *Wrightia tinctoria* plant, a small deciduous tree commonly known as "Sweet Indrajao" or "Pala indigo." It is a staple in traditional Ayurvedic medicine, particularly for the treatment of psoriasis and other inflammatory skin disorders. The oil contains various phytochemicals, including flavonoids, steroids, and triterpenoids, which provide anti-inflammatory, analgesic, and wound-healing properties. In modern pharmaceutical research, it is being investigated as a synergistic component in advanced topical delivery systems, such as lyotropic liquid crystals and film-forming gels, to improve the solubility and efficacy of hydrophobic drugs like pimecrolimus. Its primary mechanism involves the downregulation of pro-inflammatory cytokines and the modulation of the skin's immune response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wrightia tinctoria oil.